Boston, MA – On June 5, Governor Charles Baker visited Bulfinch-managed Osborn Triangle in Cambridge. Governor Baker toured the headquarters at LabCentral, a shared laboratory space for high-potential life-sciences and biotech startups, where some of the 65 companies are now tackling COVID-19.
Acquired in May 2019, the three-building office and lab complex is located in the Kendall Square neighborhood of Cambridge and was sold to Harrison Street Real Estate Capital in partnership with Bulfinch. Bulfinch is the property manager for the complex, which spans three buildings: 610 Main St. North, 1 Portland St. and 700 Main St. for a combined 667,000sf, alongside a 650-space parking garage. Tenants currently include Pfizer, Novartis International AG, and Lab Central.
The Bulfinch Companies, Inc. (Bulfinch) also announces its expanded life science property management team has been overseeing changes to safety protocols at all life science assets. This change comes amid the COIVD-19 pandemic, as many life science and medical tenants remain at properties to research and assist with managing the coronavirus outbreak.
As many life science companies remain open as essential businesses during this time, it has been critical for Bulfinch to implement protocols and procedures enabling properties to remain open, while also enhancing safety precautions. Bulfinch has devised many operational changes at its properties to minimize the spread of pathogens, including: increased sanitation of public spaces, incorporating protective glass partitions for reception desks, plastic covers on elevator buttons, updated UV lighting with photo ionization in select areas, and Merv 13 air filtration where possible. Moreover, Bulfinch has also implemented on-site EMTs and screening procedures to further enhance safety at all properties.
Bulfinch’s new life science property management team is led by Rob Brierley, VP of property management, and Laura Tower, AVP of property management. Brierley and Tower have worked closely with Bulfinch’s senior leadership in strategic planning and operations.
Additionally, Bulfinch’s new 286,000sf lab and office building at Cambridge Discovery Park (CDP) recently opened in Q1 2020. Building 400-500 is the latest lab and office development in the Alewife life science cluster and joins three existing lab and office buildings on CDP’s campus which Bulfinch owns and operates.